相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Akt Mediates GSK-3β Phosphorylation in the Rat Prefrontal Cortex during the Process of Ketamine Exerting Rapid Antidepressant Actions
Wei Zhou et al.
NEUROIMMUNOMODULATION (2014)
The Role of Eukaryotic Elongation Factor 2 Kinase in Rapid Antidepressant Action of Ketamine
Lisa M. Monteggia et al.
BIOLOGICAL PSYCHIATRY (2013)
Activation of Mammalian Target of Rapamycin and Synaptogenesis: Role in the Actions of Rapid-Acting Antidepressants
Jason M. Dwyer et al.
BIOLOGICAL PSYCHIATRY (2013)
Sex differences in the antidepressant-like effects of ketamine
Nicole Carrier et al.
NEUROPHARMACOLOGY (2013)
GSK-3 Inhibition Potentiates the Synaptogenic and Antidepressant-Like Effects of Subthreshold Doses of Ketamine
Rong-Jian Liu et al.
NEUROPSYCHOPHARMACOLOGY (2013)
Antidepressant effects of ketamine: mechanisms underlying fast-acting novel antidepressants
Caroline A. Browne et al.
FRONTIERS IN PHARMACOLOGY (2013)
Therapeutic Potential of Mood Stabilizers Lithium and Valproic Acid: Beyond Bipolar Disorder
Chi-Tso Chiu et al.
PHARMACOLOGICAL REVIEWS (2013)
Course of Improvement in Depressive Symptoms to a Single Intravenous Infusion of Ketamine vs Add-on Riluzole: Results from a 4-Week, Double-Blind, Placebo-Controlled Study
Lobna Ibrahim et al.
NEUROPSYCHOPHARMACOLOGY (2012)
Glutamate N-methyl-D-aspartate Receptor Antagonists Rapidly Reverse Behavioral and Synaptic Deficits Caused by Chronic Stress Exposure
Nanxin Li et al.
BIOLOGICAL PSYCHIATRY (2011)
Lentivirally mediated GSK-3β silencing in the hippocampal dentate gyrus induces antidepressant-like effects in stressed mice
Naoto Omata et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2011)
Inhibition of ketamine-induced hyperlocomotion in mice by the essential oil of Alpinia zerumbet: possible involvement of an antioxidant effect
Fernanda Yvelize Ramos de Araujo et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2011)
Inhibition of glycogen synthase kinase-3 is necessary for the rapid antidepressant effect of ketamine in mice
E. Beurel et al.
MOLECULAR PSYCHIATRY (2011)
NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses
Anita E. Autry et al.
NATURE (2011)
The mTOR signaling pathway in the prefrontal cortex is compromised in major depressive disorder
Courtney S. Jernigan et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2011)
Behavioral alterations and pro-oxidant effect of a single ketamine administration to mice
Francisca Charliane Carlos da Silva et al.
BRAIN RESEARCH BULLETIN (2010)
Rapid Resolution of Suicidal Ideation After a Single Infusion of an N-Methyl-D-Aspartate Antagonist in Patients With Treatment-Resistant Major Depressive Disorder
Nancy DiazGranados et al.
JOURNAL OF CLINICAL PSYCHIATRY (2010)
Molecular actions and therapeutic potential of lithium in preclinical and clinical studies of CNS disorders
Chi-Tso Chiu et al.
PHARMACOLOGY & THERAPEUTICS (2010)
mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists
Nanxin Li et al.
SCIENCE (2010)
A role for nitrergic system in the antidepressant-like effects of chronic lithium treatment in the mouse forced swimming test
Mehdi Ghasemi et al.
BEHAVIOURAL BRAIN RESEARCH (2009)
The acute effects of NMDA antagonism: From the rodent to the human brain
Handan Gunduz-Bruce
BRAIN RESEARCH REVIEWS (2009)
Different sub-anesthetic doses of ketamine increase oxidative stress in the brain of rats
Larissa de Oliveira et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2009)
The STAR*D Trial: Revealing the Need for Better Treatments
Thomas R. Insel et al.
PSYCHIATRIC SERVICES (2009)
The mood stabilizers lithium and valproate selectively activate the promoter IV of brain-derived neurotrophic factor in neurons
S. Yasuda et al.
MOLECULAR PSYCHIATRY (2009)
A β-arrestin 2 signaling complex mediates lithium action on Behavior
Jean-Martin Beaulieu et al.
CELL (2008)
Lithium blocks stress-induced changes in depressive-like behavior and hippocampal cell fate:: The role of glycogen-synthase-kinase-3β
R. Silva et al.
NEUROSCIENCE (2008)
Acute administration of ketamine induces antidepressant-like effects in the forced swimming test and increases BDNF levels in the rat hippocampus
Leda S. B. Garcia et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2008)
Lack of persistent effects of ketamine in rodent models of depression
Piotr Popik et al.
PSYCHOPHARMACOLOGY (2008)
A rational mechanism for combination treatment of Huntington's disease using lithium and rapamycin
Sovan Sarkar et al.
HUMAN MOLECULAR GENETICS (2008)
Oxidative stress parameters in unmedicated and treated bipolar subjects during initial manic episode: A possible role for lithium antioxidant effects
Rodrigo Machado-Vieira et al.
NEUROSCIENCE LETTERS (2007)
Alteration in kinase activity but not in protein levels of protein kinase B and glycogen synthase kinase-3β in ventral prefrontal cortex of depressed suicide victims
Felicien Karege et al.
BIOLOGICAL PSYCHIATRY (2007)
Effect of MK-801 and ketamine on hydroxyl radical generation in the posterior cingulate and retrosplenial cortex of free-moving mice, as determined by in vivo microdialysis
Dai-Ying Zuo et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2007)
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression
Carlos A. Zarate et al.
ARCHIVES OF GENERAL PSYCHIATRY (2006)
Effect of 5-HT3 receptor antagonist MDL 72222 on behaviors induced by ketamine in rats and mice
T Kos et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2006)
Behavioral effects of ketamine and toxic interactions with psychostimulants
Tamaki Hayase et al.
BMC NEUROSCIENCE (2006)
Lithium in the prevention of suicidal behavior and all-cause mortality in patients with mood disorders: A systematic review of randomized trials
A Cipriani et al.
AMERICAN JOURNAL OF PSYCHIATRY (2005)
Comparative and interactive human psychopharmacologic effects of ketamine and amphetamine - Implications for glutamatergic and dopaminergic model psychoses and cognitive function
JH Krystal et al.
ARCHIVES OF GENERAL PSYCHIATRY (2005)
Strategies for productring faster acting antidepressants
A Adell et al.
DRUG DISCOVERY TODAY (2005)
The tail suspension test as a model for assessing antidepressant activity: Review of pharmacological and genetic studies in mice
JF Cryan et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2005)
Repeated restraint stress induces oxidative damage in rat hippocampus
F Fontella et al.
NEUROCHEMICAL RESEARCH (2005)
NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development
JH Krystal et al.
PSYCHOPHARMACOLOGY (2003)
Melatonin exerts an antidepressant-like effect in the tail suspension test in mice:: evidence for involvement of N-methyl-D-aspartate receptors and the L-arginine-nitric oxide pathway
M Mantovani et al.
NEUROSCIENCE LETTERS (2003)
Lithium, but not valproate, induces the serine/threonine phosphatase activity of protein phosphatase 2A in the rat brain, without affecting its expression
S Tsuji et al.
JOURNAL OF NEURAL TRANSMISSION (2003)
Lipid peroxidation and antioxidant enzyme levels in patients with schizophrenia and bipolar disorder
M Kuloglu et al.
CELL BIOCHEMISTRY AND FUNCTION (2002)
Lithium inhibits the development of physical dependence to clonidine in mice
AR Dehpour et al.
PHARMACOLOGY & TOXICOLOGY (2002)
Chronic lithium treatment increases the expression of brain-derived neurotrophic factor in the rat brain
T Fukumoto et al.
PSYCHOPHARMACOLOGY (2001)
Regulation of elongation factor 2 kinase by p90RSK1 and p70 S6 kinase
XM Wang et al.
EMBO JOURNAL (2001)
Antidepressant effects of ketamine in depressed patients
RM Berman et al.
BIOLOGICAL PSYCHIATRY (2000)
分享论文
